Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
151 Cards in this Set
- Front
- Back
Three goals of PFTs
|
1. identify pts at r/f increased mort/morb post op
2. identify pts who need short or long term ventilatory support 3. evaluate the benefit of reversing airway obstruction with bronchodilators |
|
Anesthesia-specific goal of PFTs
|
predict if will need vented post op
|
|
Remember that PFTs are used
|
- not used alone - used to support/exclude dx
- typically in combination with hx, exam, labs, dx studies to establish a diagnosis |
|
What is FEV-1
|
volume exhaled in first second of FVC maneuver
|
|
What is FEF 25-75%
|
mean expiratory flow - middle half of FVC maneuver
|
|
What is FEF 25-75% good for measuring
|
small airway diseases - reflects <2mm diameter airways
|
|
What is FVC
|
forced vital capacity - max amount of air that can be exhaled forcefully and as rapidly as possible after maximum inhalation
|
|
Normal individual total expiratory time
|
4-6 sec
|
|
What are the expiratory times of a pt with an obstructive lung disease
|
longer than 4-6 sec
|
|
FVC for COPD patients are typically
|
decreased due to air trapping
|
|
FEVT is
|
forced expired volume in a given amount of time
|
|
FEV-1 are decreased in what type patients
|
obstructive and restrictive disease patterns
|
|
Normal FEV-1 is
|
80%
|
|
What is the actual calculation of FEV-1
|
(FEV @ 1sec/FVC) x 100%
|
|
FEV-1 decreases with
|
age
|
|
What's another name for FEF 25-75%
|
MMEF (maximal mid expiratory flow)
|
|
Peak expiratory flow (PEF) or peak flow is
|
the speed of air moving out of the lungs at the beginning of exhalation
|
|
TET
|
Total expiratory time
|
|
t
|
Forced expiratory volume
|
|
Two categories of lung pathology
|
obstructive and restrictive
|
|
Obstructive lung pathology refers to
|
flow problem
|
|
Restrictive lung pathology refers to
|
volume problem
|
|
Which lung pathology is more frequent cause of lung dysfunction
|
obstructive - flow problem
|
|
obstructive airways are characterized by
|
limitation of expiratory airflow - so airways cannot empty as rapidly as normal
|
|
Narrowed airways/bronchospasm/inflammatation are examples of
|
obstructive disorders
|
|
Examples of obstructive airway disorders include
|
asthma, emphysema, cystic fibrosis
|
|
Restrictive airways are characterized by
|
reduced lung volume/decreased lung compliance
|
|
Examples of restrictive airway disorders include
|
interstitial fibrosis, scoliosis, obesity, lung resection, neuromuscular diseases, cystic fibrosis
|
|
It is not uncommon for a disease to have
|
obstructive and resistive components
|
|
Is cystic fibrosis obstructive or resistive airway disease
|
both
|
|
PFT change is obstructive if
|
FEV-1 and FVC are low AND FEV-1/FVC < 0.7
|
|
Normal FVC is
|
5L
|
|
Normal FEV-1 is ~
|
4L
|
|
PFT change is resistive if
|
FEV-1 and FVC are low AND FEV-1/FVC > 0.7
|
|
Can you tell if pt has both restrictive and obstructive lung disease with PFT
|
no
|
|
If FEV-1 < 2L and FEV-1/FVC < 50%
|
must have more sophisticated split lung functions tests before proceeding with case that will impact lung (pneumonectomy)
|
|
FVC wnl or low
FEV-1 low FEF 25-75% low FEV-1/FVC low TLC wnl or high |
COPD
|
|
COPD pt - why is TLC high
|
air trapping
|
|
FVC low
FEV-1 low FEF 25-75% wnl or low FEV-1/FVC wnl to high TLC low |
restrictive disorders
|
|
FEV-1 = 3.6 L ; FVC = 4.8 L
|
0.75 = restrictive
|
|
FEV-1 = 1.8 L ; FVC = 2.2 L
|
0.82 = restrictive
|
|
FEV-1 = 2.2 L ; FVC = 4.8 L
|
0.46 = obstructive
|
|
Are PFT tests usually performed before or after bronchodilator tx
|
both
|
|
Positive response in considered in bronchodilator therapy when there is a
|
15% improvement in PFT
|
|
If there is a 15% improvement
|
I think bronchodilator therapy should be started post op
|
|
For bronchodilator therapy, look at improvement in which tests
|
FVC, FEV-1 and FEF 25-75%
|
|
Which types of lung disorders typically respond better to bronchodilator therapy
|
obstructive
|
|
TLC decreases how much after abdominal surgery
|
25-50%
|
|
TLC decreases how much after extremity surgery
|
no change
|
|
How long after general anesthesia does it take for VC to return to normal
|
1-2 weeks
|
|
VC correlates with ability to
|
cough and deep breathe
|
|
Forced VC is dependent on a patient's
|
effort and cooperation
|
|
How much of a reduction in vital capacity is there after abdominal and thoracic surgery
|
60%
|
|
How long does it take vital capacity to return to normal after abdominal and thoracic surgery
|
7-10 days
|
|
Why does it take so long for vital capacity to return to normal after abdominal and thoracic surgery
|
because of the reflex diaphragmatic dysfunction due to surgical incision or presence of intraperitoneal or intrathoracic air versus post op pain
|
|
What forced vital capacity is associated with post op pulmonary complications
|
< 15 ml/kg
|
|
Post op - the RV increases by how much after abdominal surgery
|
13%
|
|
Post op - the ERV decreases by how much after abdominal surgery
|
25%
|
|
Post op - TV decreases _____ within 24 hours, then returns to normal after _____
|
20%, two weeks
|
|
Post op - pulmonary compliance decreases by
|
22%
|
|
Post op - FRC decreases by
|
22%, due to small airway closures
|
|
Ideally, the FRC is greater than
|
the closing capacity
|
|
Post op - If FRC < closing capacity
|
airways close and have increased shunting
|
|
Post op - Upper abdominal surgeries reduce FRC by
|
40-50%
|
|
What are associated with the highest incidence of post op lung complications
|
upper abdominal surgeries
|
|
Post op - upper abdominal surgeries - how long does it take for FRC to recover
|
3-7 days
|
|
Post op - upper abdominal surgeries - how long does it take for FRC to recover if CPAP is used
|
72 hours
|
|
Post op - lower abdominal surgeries - can reduce FRC by
|
30%
|
|
Of FiO2 is 50% - what should the PaO2 be
|
250 torr (mult FiO2 x 5)
|
|
Of FiO2 is 21% - what should the PaO2 be
|
105 torr (mult FiO2 x 5)
|
|
If know FiO2 - send an ABG to find PaO2 - what can you determine
|
if you have a delivery problem, underventilation problem, or lung problem
|
|
Of FiO2 is 50% - what should the PAO2 (alveolar) be
|
300 torr (mult FiO2 x 6)
|
|
Of FiO2 is 21% - what should the PAO2 (alveolar) be
|
126 torr (mult FiO2 x 6)
|
|
If V and Q were perfectly matched - how much gradient difference would there be between PaO2 and PAO2
|
zero
|
|
In reality (normal) how much is the gradient difference between PaO2 and PAO2
|
5-15torr (on 21% FiO2)
|
|
Which has a higher gradient PaO2 or PAO2
|
PAO2 (remember the formula)
|
|
If V and Q were perfectly matched - how much gradient difference would there be between PaCO2 and PACO2
|
zero
|
|
In reality (normal) how much is the gradient difference between PaCO2 and PACO2
|
2-10torr
|
|
Is the gradient difference between PaCO2 and PACO2 affected by FiO2
|
no
|
|
ETCO2 can be substituted for PaCO2 or PACO2
|
PACO2
|
|
Which is higher PaCO2 or PACO2
|
not sure - need answer here
|
|
If a patient hypoventilates - what happens to the gradients
|
no change
|
|
if there is V:Q mismatching - what happens to the gradients
|
the gradients will change
|
|
If the gradient is normal and the patient is hypoxic
|
you have a ventilation problem
|
|
If the gradient is increased and the patient is hypoxic
|
you have a V:Q problem
|
|
Determine problem:
PaCO2 = 60torr - ETCO2 = 45torr |
gradient = 60-45 = 15
normal = 2-10 have V:Q problem |
|
Determine problem:
PAO2 = 55torr - PaO2 = 45torr |
gradient - 55-45 = 10
normal - 2-10 have ventilation or O2 delivery problem |
|
LOOK AT FLOW LOOPS
|
LOOK AT FLOW LOOPS
|
|
LOOK AT FLOW LOOPS
|
LOOK AT FLOW LOOPS
|
|
Origin of work capnography
|
kapnos - greek meaning smoke
|
|
where is capnography sampled
|
at the Y connector, mask or NC
|
|
Capnography gives insights into
|
ventilation, cardiac output, distribution of pulmonary blood flow, metabolic activity
|
|
Capnography refers to
|
waveform
|
|
Capnometry refers to
|
monitor (digital)
|
|
Two techniques for monitoring ETCO2
|
mainstream and sidestream
|
|
Two other terms for mainstream ETCO2 monitoring
|
flow-through or in-line
|
|
Describe mainstream ETCO2 monitoring adv and disadv
|
adapter placed in breathing circuit
no gas removed from the airway adds bulk to breathing system electronics are vulnerable mechanical damage |
|
Another term for sidestream analyzer
|
aspiration analyzer
|
|
Describe how sidestream analyzer works
|
aspirate gas from airway sampling site transported to remote CO2 analyzer
|
|
Adv of sidestream analyzer
|
ability to analyze multiple gases
can use on non ETT pts |
|
Disadv of sidestream analyzer
|
potential for disconnect or leak - giving false readings
water vapor condenses |
|
What device is used to protect analyzer optics
|
(water trap
|
|
Where is the water trap placed in the system
|
between sample line and analyzer
|
|
How much does sidestream analyzer withdrawal
|
usually 50-500 ml/min
|
|
Does the location of the ETCO2 analyzer matter
|
yes
|
|
ETCO2 measurements made further away from the alveolus can
|
become mixed with fresh gas - causing dilution of CO2 values and rounding of capnogram
|
|
Would you be able to see the rounding on a capnometer
|
no - it's a digital readout - but the number should be lower
|
|
ETCO2 measures the
|
CO2 concentration of exhaled gas (duh!)
|
|
Photodetector measures the amount of what type of light during inspiration and expiration
|
infrared
|
|
CO2 molecules absorb specific
|
wavelengths of infrared light energy
|
|
Light absorption increases directly with
|
CO2 concentration
|
|
A monitor converts the output from the infrared light absorber to the
|
capnogram (waveform)
|
|
LOOK UP PULSE OX
|
LOOK UP PULSE OX
|
|
STUDY CAPNOGRAPHY WAVEFORMS
|
STUDY CAPNOGRAPHY WAVEFORMS
|
|
How does an ETCO2 work
|
uses infrared light to detect CO2 concentration of exhaled gas
|
|
Light absorption increases as
|
CO2 level increases
|
|
Four phases of capnogram
|
I, II, III, IV
|
|
Phase I - AB represents
|
exhalation of anatomic deadspace - normally devoid of CO2
|
|
Phase II - BC represents
|
(sharp upstroke of wave) - determined by evenness of ventilation and alveolar emptying
|
|
End of phase II signifies
|
usual end of expiration
|
|
Phase III - CD represents
|
exhalation of alveolar gas - considered expiratory pause
|
|
Point D designates
|
end-tidal CO2 concentration (most accurate)
|
|
Phase IV - DE represents
|
beginning of inspiration - normally gases lacing CO2 and approaching zero
|
|
Purpose of capnogram
|
provide validation of ETCO2 value
visual assmt of pt airway integrity verification of proper ETT placement assmt of ventilator/breathing circuit intregity |
|
Causes of decreasing waveform to minimal
|
missed intubation - in esophagus
|
|
causes of small amplitude, then trailing waveform
|
leaky or deflated ETT cuff
artificial airway is too small for pt (obstruction) connections on sample tubing loose |
|
Causes for increasing ETCO2 trend
|
hypoventilation - RR or TV
increased metabolic rate increased temperature release of tourniquet absorption of CO2 from peritoneal insufflation sudden increase in BP |
|
Causes for gradual decreasing ETCO2 trend
|
hyperventilation - RR or TV
decrease in metabolic rate decrease in temperature |
|
Causes for rapid decreasing ETCO2 trend
|
air or thrombus embolus
sudden hypotension circulatory arrest bone cement |
|
Cause for inspired CO2 (rise in baseline)
|
CO2 absorbent exhausted
faulty expiratory valve calibration error in monitor water in analyzer |
|
Cause for loss of plateau/sloping of ETCO2 waveform
|
obstruction of expiration (COPD, asthma, bronchospasm)
A-a gradient increased No plateau is reached prior to next inspiration kinked ETT |
|
Cause for cleft in phase III of waveform
|
pt is inspiring during exhalation phase
muscle relaxant levels subsiding PaCO2 increasing causing spontaneous respiration increasing pain in older texts - referred to as Curare cleft |
|
Cause for cardiogenic oscillations
|
by beating of heart against lungs
may be seen more as relaxant wears off and tone returns to chest, abd wall and diaphragm |
|
Cardiogenic oscillations are seen more in what population
|
pediatrics because chest takes up more space in chest cavity
|
|
Ketorolac article - for our info
|
24 y/o/f administered ketorolac at end of a case for post op pain - awake extubated and sent to PACU - after 15 min in the PACU, started having problems breathing - admin terbutiline for bronchodilation - condition did not improve - administered aminophylline, midazolam, methylprednisolone - meanwhile re-intubated - given H1 and H2 blockers (diphenhydramine and rantitidine) simultaneously - extubated and watched overnight
|
|
Article - bronchial asthma is the
|
most common obstructive airway disease - 3-6% of population
|
|
Article - What is the aspirin triad
|
aspirin intolerance, asthma, nasal polyps
|
|
Article - pts with aspirin triad are also
|
sensitive to derivatives of benzoic acid, so caution should be used with ester-type anesthetics
|
|
Article - NSAIDs (ibuprofen, ketorolac, and naproxen) may induce
|
asthmatic episodes due to cross-sensitivity to aspirin and/or increased leukotriene production
|
|
Article - Three types of bronchial asthma
|
exercised-induced, extrinsic, and aspirin-induced
|
|
Article - Exercise-induced asthma is characterized by
|
bronchoconstriction with increased physical activity and decreasing wall temperature
|
|
Article - Exercise-induced asthma is typically managed with
|
inhaled beta adrenergic agonists
|
|
Article - Extrinsic asthma is AKA
|
environmentally induced asthma
|
|
Article - Extrinsic asthma is induced by
|
exposure of inhaled allergenic substances to IgE antibodies
|
|
Article - Extrinsic asthma takes how long for symptoms to manifest
|
minutes to several hours - but acute attacks are not usual
|
|
Article - Aspirin-induced asthma is often correlated with
|
intrinsic type astham
|
|
Article - Aspirin-induced asthma takes how long for symptoms to manifest
|
almost immediately or delayed up to 8hrs
|
|
Article - Treatment of aspirin-induced asthma includes
|
epinephrine (potent bronchodilator) due to direct stimulation of B2 adrenergic receptors - may need multiple doses
B2 receptor agonists (terbutaline, metaproterenol, albuterol) |
|
Article - Treatment of aspirin-induced asthma includes
|
In both cases, they administered both H1 and H2 anagonists (diphenhydramine and ranitidine)
|
|
Article - aspirin is second to penicillin in producing
|
allergic drug reactions
|
|
Article - aspirin intolerance is
|
not a true drug allergy
|